An interesting, timely – and rejected – criticism of psychedelic research.
The key points of a recent paper critiquing a recent analyis of fMRI data from two clinical trials.
Blossom’s Bits
Five upcoming psychedelic clinical trials you don’t want to miss
Here are five upcoming clinical trials we’re excited about.
How you can enhance the psychedelic experience – without taking more
There are ways to intensify a psychedelic experience without taking more of a substance. Here are three possible ways.
What are the most interesting ongoing clinical trials with psychedelics?
Here are five ongoing clinical trials that have got our attention.
Meet the psychiatrist initiating the world’s first MDMA-assisted therapy trial for depression
We caught up with Tor-Morten Kvam who is working on the world’s first trial using MDMA-assisted therapy for depression.
The long & short of psychedelic-assisted therapy. Part 2 – Maximalists.
What psychedelic therapy will look like is currently a hot debate. Here we provide four points on the maximalists side of the argument.
The long & short of psychedelic-assisted therapy. Maximalists vs minimalists.
What psychedelic therapy will look like is currently a hot debate. Here we provide four points on the minimalist side of the argument.
Learn what psychoneuroimmunology is from Attila Szabo
With 20 years of experience under his belt, Dr Attila Szabo is the perfect person to tell us what “psychoneuroimmunology” is – and why you should learn what the heck it means.
Happy Easter. Here is what we know about Christianity and psychedelics.
Psychedelics and Christianity are not two things that usually fit through the same door, here are some of the ways the two are intertwined.
Happy Bicycle Day. This is how it came to be on the 19th – and not the 16th – of April.
When Albert Hofmann was 37 years old, he experienced the world’s first LSD trip on the 19th of April 1943 in Basel, Switzerland.